Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMP-028 interaction study with combined oral contraceptive in healthy women
NL-OMON34656Active, not recruiting
- Sponsor
- Sumitomo Pharma
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of SMP-028, ethinylestradiol + levonorgestrel, ethinyl estradiol and avatrombopag in asthma (2 arms), sponsored by Sumitomo Pharma. Primary endpoint: Pharmacokinetics of Microgynon 30. Started Jan 2010; status: active, not recruiting.
02
Drugs
SMP-028ethinylestradiol + levonorgestrelethinyl estradiolavatrombopag
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON34656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34656.